Unprecedented Abstract Highlights Addyi’s Remarkable Effects on Low Libido among Breast Cancer Patients
IRVINE, CA – July 5, 2023 – The Ad Firm is thrilled to announce the publication of an abstract by Sprout Pharmaceuticals, showcasing the remarkable effects of Addyi (flibanserin) on low libido among breast cancer patients. This study, presented at the ASCO …